Clinical Trials on Uterus Dysfunction in Japan

Total 35 results

Bayer

Completed

LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers

Erectile Dysfunction

Japan
Bayer

Completed

LEVITRA® 20mg Special Drug Use Investigation (Long-term)

Erectile Dysfunction

Japan
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection

Impotence

Japan
Tokyo Medical University

Recruiting

Development of Three Dimensional Preoperative Planning System for the Osteosynthesis of Distal Humerus Fractures

Distal Humerus Fracture

Japan
Bayer

Completed

BAY38-9456 - Supportive Trial for Spinal Injury

Sexual Dysfunction | Erectile Dysfunction | Spinal Cord Injury

Japan
Sapporo Medical University

Completed

Optimization of Desflurane in Elderly Patients

Postoperative Cognitive Dysfunction

Japan
Mallinckrodt

Completed

Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery

Hypertension, Pulmonary | Ventricular Dysfunction, Left

Japan
Kyoto University

Completed

Bowel, Urinary and Sexual Function After Laparoscopic Colorectal Surgery

Sexual Dysfunction, Physiological | Colorectal Surgery | Surgery, Laparoscopic

Japan
Japan Society of Clinical Research

Completed

Evaluation of mediVR-KAGURA Guided Therapy

Cognitive Dysfunction | Physical Disability

Japan
Novartis

Completed

SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction

Hypertension

Japan
National Cerebral and Cardiovascular Center

Completed

A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)

Mild Cognitive Impairment

Japan
University of Shizuoka

Completed

Effects of Green Tea Consumption on Homocysteine Metabolism and Cognitive Dysfunction

Cognitive Impairment

Japan
Kumamoto University

Terminated

Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study

Hypertension

Japan
Hamamatsu University

Suspended

Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia

Schizophrenia | Negative Symptoms | Cognitive Impairments

Japan
Avid Radiopharmaceuticals
Eli Lilly and Company

Completed

A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease

Japan
University of Jazan

Completed

Effectiveness Of Computer-Based Cognitive Training in Age-Related Cognitive Decline

Age-related Cognitive Decline

Saudi Arabia
Tokyo Medical and Dental University

Completed

Randomized Clinical Trial of Treatment for Temporomandibular Joint (TMJ) Disc Displacement

Temporomandibular Disorders | Herniated Disk

Japan
Nara Medical University

Completed

Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline

Hypertension | Brain Infarction

Japan
Novartis Pharmaceuticals

Completed

Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction

Hypertension With Renal Dysfunction

Japan
Naofumi Takehara
National Cerebral and Cardiovascular Center; Translational Research Center... and other collaborators

Completed

AutoLogous Human CArdiac-Derived Stem Cell to Treat Ischemic cArdiomyopathy (ALCADIA) (ALCADIA)

Ventricular Dysfunction | Congestive Heart Failure | Ischemic Cardiomyopathy

Japan
Eisai Co., Ltd.

Completed

A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Alzheimer's Disease

Japan
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., Japan

Completed

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

Polycystic Ovarian Syndrome | Anovulation | Oligo-ovulation | Hypothalamic-pituitary Dysfunction

Japan
University Hospital, Lille

Completed

Pre-stroke Cognitive Status and Thrombolytic Therapy (OPHELIE-COG)

Brain Ischemia | Dementia | Adverse Effect of Thrombolytic Drugs | Impaired Cognition

France, Japan
Eli Lilly and Company

Terminated

A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Healthy | Mild Cognitive Impairment | Alzheimer's Disease

United States, Japan
Eli Lilly and Company

Completed

A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Alzheimer Disease

United States, Japan, United Kingdom
Abbott Medical Devices

Completed

St.Jude Medical Cardiac Lead Assessment Study (CLAS)

Externalized Conductors | Visual Lead Anomalies | Electrical Dysfunction

United States, Japan, Canada
Bayer

Active, not recruiting

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction (LEPHT)

Hypertension, Pulmonary | Ventricular Dysfunction, Left

Belgium, France, China, Spain, Japan, United States, Singapore, Canada, Switzerland, Austria, Denmark, Germany, Italy, Australia, Czechia, Netherlands, Poland, United Kingdom
Regeneron Pharmaceuticals

Recruiting

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Non-Alcoholic Steatohepatitis (NASH) in Adult Participants at Increased Genetic Risk for This Condition (NASHGEN-2)

Non-alcoholic Steatohepatitis (NASH) | Metabolic Dysfunction Associated Steatohepatitis (MASH)

United States, Korea, Republic of, Puerto Rico, Japan
Biogen

Completed

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) (TALLY)

Cognitive Impairment Associated With Schizophrenia

Spain, United States, Germany, Japan, United Kingdom
Eli Lilly and Company

Terminated

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Alzheimer's Disease

United States, Italy, Japan, Spain, Netherlands
Medtronic Cardiac Rhythm and Heart Failure

Completed

Safety and Clinical Performance of the Protecta ICD and CRT-D

Heart Failure | Ventricular Dysfunction | Tachyarrhythmias

United States, Netherlands, Colombia, South Africa, Japan, Israel, Spain, Canada, United Kingdom, Germany, Slovenia, Sweden, Saudi Arabia, Switzerland, Malaysia, Austria, Czechia, Denmark, India, Italy, United Arab Emirates
Boehringer Ingelheim

Completed

BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Alzheimer Disease

Spain, United Kingdom, Italy, United States, Canada, Germany, Greece, Austria, Norway, France, Japan, Hungary, Poland, Finland
Janssen Research & Development, LLC

Active, not recruiting

A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease (Autonomy)

Cognitive Dysfunction | Dementia | Alzheimer Disease

United States, Belgium, France, Japan, United Kingdom, Spain, Canada, Australia, Sweden, Netherlands
Boehringer Ingelheim

Completed

Special Survey on PD Patients With Renal Dysfunction

Parkinson Disease

Japan
Biogen

Recruiting

A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age (CELIA)

Mild Cognitive Impairment Due to Alzheimer's Disease | Alzheimer's Disease Dementia

Belgium, United States, Australia, Italy, Spain, Denmark, United Kingdom, Czechia, France, Poland, Switzerland, Germany, Canada, Japan, Finland, Netherlands, Sweden

Clinical Trials on Uterus Dysfunction in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations